AR024746A1 - Androgenos oralmente activos. - Google Patents
Androgenos oralmente activos.Info
- Publication number
- AR024746A1 AR024746A1 ARP000103625A ARP000103625A AR024746A1 AR 024746 A1 AR024746 A1 AR 024746A1 AR P000103625 A ARP000103625 A AR P000103625A AR P000103625 A ARP000103625 A AR P000103625A AR 024746 A1 AR024746 A1 AR 024746A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- oralally
- active androgens
- acyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Nuevos androgenos oralmente activos son derivados de delta14-nandrolona 7alfa-sustituidos. Los compuestos satisfacen la formula general 1 donde R1 es O,(H, H), (H, OR), NOR, siendo R hidrogeno, (C1-6)alquilo o (C1-.6)acilo; R2 se selecciona delgrupo consistente en (C2-4)alquilo, (C2-4)alquenilo o(C2-4)alquinilo, cada uno opcionalmente sustituido por halogeno; o R2 es ciclopropilo o ciclopropenilo, cada uno opcionalmente sustituido por (C1-2)alquilo ohalogeno; R3 es hidrogeno,(C1-2)alquilo o e tenilo; R4 es (C1-2) alquilo; R5 es hidrogeno o (C1-15)acilo; y las líneas de puntos indican enlaces opcionales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99202348 | 1999-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR024746A1 true AR024746A1 (es) | 2002-10-23 |
Family
ID=8240463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000103625A AR024746A1 (es) | 1999-07-16 | 2000-07-14 | Androgenos oralmente activos. |
Country Status (28)
Country | Link |
---|---|
US (3) | US6313108B1 (es) |
EP (1) | EP1203011B1 (es) |
JP (1) | JP2003505394A (es) |
KR (1) | KR20020092890A (es) |
CN (1) | CN1360589A (es) |
AR (1) | AR024746A1 (es) |
AT (1) | ATE257159T1 (es) |
AU (1) | AU770412B2 (es) |
BR (1) | BR0012489A (es) |
CA (1) | CA2379223A1 (es) |
CO (1) | CO5200765A1 (es) |
CZ (1) | CZ2002192A3 (es) |
DE (1) | DE60007530T2 (es) |
ES (1) | ES2213596T3 (es) |
HK (1) | HK1043797A1 (es) |
HU (1) | HUP0201952A3 (es) |
IL (1) | IL147332A0 (es) |
MX (1) | MXPA02000601A (es) |
NO (1) | NO20020222L (es) |
NZ (1) | NZ516525A (es) |
PE (1) | PE20010330A1 (es) |
PL (1) | PL353007A1 (es) |
RU (1) | RU2002103883A (es) |
SK (1) | SK712002A3 (es) |
TR (1) | TR200200076T2 (es) |
TW (1) | TW548277B (es) |
WO (1) | WO2001005806A1 (es) |
ZA (1) | ZA200200106B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000059920A2 (en) * | 1999-04-06 | 2000-10-12 | Akzo Nobel N.V. | Orally active 7.alpha.-alkyl androgens |
AU4966101A (en) * | 2000-03-31 | 2001-10-15 | Us Gov Health & Human Serv | Methods of making and using 7alpha,11beta-dimethyl-17beta-hydroxy-4-estren-3-one17beta-trans-4-m-butylcyclohexane carboxylate and 7alpha,11beta-dimethyl-17beta -hydroxyestr-4-en-3-one 17-undecanoate |
US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
SK882003A3 (en) * | 2000-07-28 | 2003-07-01 | Akzo Nobel Nv | 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use |
ATE321557T1 (de) * | 2001-03-30 | 2006-04-15 | Us Gov Health & Human Serv | Verfahren zur herstellung von 7alpha,11beta- dimethyl-17beta-hydroxyestra-4, 14-dien-3-one, dessen 17-ester und pharmazeutische zubereitungen die sie enthalten |
ES2336439T3 (es) * | 2002-01-21 | 2010-04-13 | N.V. Organon | Proceso para la preparacion de 7-alfa-metilesteroides. |
GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
WO2010043404A1 (en) * | 2008-10-15 | 2010-04-22 | Synthon B.V. | Processes and intermediates for the production of fulvestrant |
CA2835979C (en) * | 2011-06-01 | 2018-05-01 | Estetra S.A. | Process for the production of estetrol intermediates |
PT2714710T (pt) | 2011-06-01 | 2016-07-12 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
BR112014008196B8 (pt) * | 2011-10-07 | 2020-12-15 | Estetra Sprl | processo para a preparação de um composto da fórmula (i) |
WO2015181116A1 (en) | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
EP3310346B1 (en) | 2015-06-18 | 2021-03-24 | Estetra SPRL | Orodispersible tablet containing estetrol |
SI3310333T1 (sl) | 2015-06-18 | 2020-08-31 | Estetra Sprl | Orodisperzibilna enota odmerka, ki vsebuje komponento estetrola |
CA2988485A1 (en) | 2015-06-18 | 2016-12-22 | Mithra Pharmaceuticals S.A. | Orodispersible tablet containing estetrol |
KR102664563B1 (ko) | 2015-06-18 | 2024-05-09 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 에스테트롤 성분을 함유하는 구강분해성 투여 단위 |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
CN110603059B (zh) * | 2017-02-23 | 2023-06-30 | 美国西门子医学诊断股份有限公司 | 化学发光雄烯二酮缀合物 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA712312B (en) * | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
-
2000
- 2000-06-27 TW TW089112646A patent/TW548277B/zh not_active IP Right Cessation
- 2000-07-10 KR KR1020027000566A patent/KR20020092890A/ko not_active Application Discontinuation
- 2000-07-10 MX MXPA02000601A patent/MXPA02000601A/es not_active Application Discontinuation
- 2000-07-10 AT AT00953032T patent/ATE257159T1/de not_active IP Right Cessation
- 2000-07-10 CN CN00810310A patent/CN1360589A/zh active Pending
- 2000-07-10 IL IL14733200A patent/IL147332A0/xx unknown
- 2000-07-10 NZ NZ516525A patent/NZ516525A/xx unknown
- 2000-07-10 ES ES00953032T patent/ES2213596T3/es not_active Expired - Lifetime
- 2000-07-10 EP EP00953032A patent/EP1203011B1/en not_active Expired - Lifetime
- 2000-07-10 RU RU2002103883/04A patent/RU2002103883A/ru unknown
- 2000-07-10 AU AU65629/00A patent/AU770412B2/en not_active Ceased
- 2000-07-10 PL PL00353007A patent/PL353007A1/xx not_active IP Right Cessation
- 2000-07-10 CZ CZ2002192A patent/CZ2002192A3/cs unknown
- 2000-07-10 CA CA002379223A patent/CA2379223A1/en not_active Abandoned
- 2000-07-10 DE DE60007530T patent/DE60007530T2/de not_active Expired - Fee Related
- 2000-07-10 TR TR2002/00076T patent/TR200200076T2/xx unknown
- 2000-07-10 SK SK71-2002A patent/SK712002A3/sk unknown
- 2000-07-10 HU HU0201952A patent/HUP0201952A3/hu unknown
- 2000-07-10 BR BR0012489-3A patent/BR0012489A/pt not_active IP Right Cessation
- 2000-07-10 WO PCT/EP2000/006544 patent/WO2001005806A1/en not_active Application Discontinuation
- 2000-07-10 JP JP2001511464A patent/JP2003505394A/ja not_active Withdrawn
- 2000-07-11 US US09/613,350 patent/US6313108B1/en not_active Expired - Fee Related
- 2000-07-13 CO CO00052876A patent/CO5200765A1/es not_active Application Discontinuation
- 2000-07-14 AR ARP000103625A patent/AR024746A1/es not_active Application Discontinuation
- 2000-07-14 PE PE2000000702A patent/PE20010330A1/es not_active Application Discontinuation
-
2001
- 2001-07-31 US US09/918,626 patent/US6541465B2/en not_active Expired - Fee Related
-
2002
- 2002-01-04 ZA ZA200200106A patent/ZA200200106B/xx unknown
- 2002-01-15 NO NO20020222A patent/NO20020222L/no not_active Application Discontinuation
- 2002-07-24 HK HK02105466.2A patent/HK1043797A1/zh unknown
- 2002-10-24 US US10/280,038 patent/US6780854B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR024746A1 (es) | Androgenos oralmente activos. | |
DE69724777D1 (de) | Pentafluorobenzensulfonamiden und analoge | |
DE122010000035I2 (de) | Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one | |
DK1382604T3 (da) | Quinolinderivater med en azolylgruppe og quinazolinderivater | |
NO20023823L (no) | Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater | |
NO20015226D0 (no) | Tri-aryl syrederivater som PPAR reseptor ligander | |
ES2269465T3 (es) | Compuestos heterociclicos de union a los receptores de la quimioquina. | |
DE60027015D1 (en) | Pseudoerythromycin-derivate | |
PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
CY1111816T1 (el) | Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου | |
TR200403436T2 (tr) | Kristalin 1-metilkarbapenem türevleri. | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
ES496451A0 (es) | Un procedimiento para la produccion de derivados de 1,2,3,4,5,6-hexahidro-6-fenil-azepino (4,5,b) indol. | |
CO5160345A1 (es) | Nuevos androgenos oralmente activos derivados de 7 alfa- metil-19-nortestosterona | |
ECSP003572A (es) | Androgenos oralmente activos | |
ES2195500T3 (es) | Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes. | |
MY139258A (en) | Carbamoyl-type benzofuran derivatives | |
AR024797A1 (es) | Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida | |
ECSP003416A (es) | Nuevos androgenos oralmente activos derivados de 7beta- metil-19- nortestosterona | |
DE69624459D1 (de) | Kondensierte indan-derivate und ihre salze | |
TR200100475T2 (tr) | N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları. | |
DE60237652D1 (de) | Variolinderivate und ihre Verwendung als Cytostatika | |
DE69828087D1 (de) | Aminderivate | |
NO20025101L (no) | Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |